Let's go, Riley
Week 7 on semaglutide · 3 of 4 sessions done · Next dose Thu
Metabolic performance · lab-driven
Stronger, lighter
- Weight today
- — lb — since Sep 9
- Lean mass
- — lb — since Sep 9
- Protein streak
- — days at 120 g or more
- Next dose
- Thu Oct 22 0.5 mg · weekly
Weight
Body weight, lb
Lean mass
Estimated lean mass, lb
Protein streak
Daily protein, last 38 days
Dose schedule
Semaglutide, once weekly
- Last doseThu Oct 15 · 0.5 mg
- Next doseThu Oct 22 · 0.5 mg
- Dose reviewNov 12 · Dr. Ava Lindqvist MD
Dose changes are made only by your clinician.
Training sessions
Week of Oct 19 · goal 4
- Lower strengthMon · 52 min
- Zone 2 walkTue · 40 min
- Upper strengthWed · 48 min
- Full bodyFri · planned
Refill tracker
Semaglutide pens
Labs
Sample lab panel, drawn Sep 11 and Oct 2
| Test | Result | Status |
|---|---|---|
| Fasting glucose | 92 mg/dL | In range |
| HbA1c | 5.3 % | In range |
| Ferritin | 41 ng/mL | In range |
| LDL cholesterol | 118 mg/dL | Watch |
| Vitamin D, 25-OH | 24 ng/mL | Watch |
| ALT | 58 U/L | Review |
| TSH | 2.1 mIU/L | In range |
Dr. Ava Lindqvist MD is reviewing the ALT result and will message you before the next draw.
Dietitian thread
Marcus Hale RD · protein and meals
Protein looked strong this week: 9 days in a row at 120 g or more. Add one more serving of Greek yogurt on lift days.
Mon 9:12 AM · Marcus Hale RDThanks. Lunches are the hard part. Any quick high-protein option at work?
Mon 9:40 AM · YouCottage cheese bowl with berries and a scoop of whey works well. Log it for two more weeks and we will review the lean-mass chart together.
Mon 10:05 AM · Marcus Hale RDCare team
Licensed clinicians on your plan
- Dr. Ava Lindqvist MDSports and obesity medicine · prescriber
- Marcus Hale RDDietitian · protein coaching
- Dr. Nia Brooks DOEndocrinology · lab review
- Tess Romero NPWomen's health · hormone check-ins
Important Safety Information
Semaglutide
WARNING: RISK OF THYROID C-CELL TUMORS. In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether it causes these tumors in people. Semaglutide is not for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects include nausea, diarrhea, vomiting, constipation and stomach pain. Serious side effects can include pancreatitis, gallbladder problems, low blood sugar and kidney problems. Semaglutide is not for use in pregnancy. Results vary. A licensed clinician decides whether this medication is right for you.